BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21123165)

  • 1. Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite.
    Dostalek M; Court MH; Hazarika S; Akhlaghi F
    Drug Metab Dispos; 2011 Mar; 39(3):448-55. PubMed ID: 21123165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
    Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
    Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
    Djebli N; Picard N; Rérolle JP; Le Meur Y; Marquet P
    Pharmacogenet Genomics; 2007 May; 17(5):321-30. PubMed ID: 17429314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.
    Shipkova M; Strassburg CP; Braun F; Streit F; Gröne HJ; Armstrong VW; Tukey RH; Oellerich M; Wieland E
    Br J Pharmacol; 2001 Mar; 132(5):1027-34. PubMed ID: 11226133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.
    Ting LS; Benoit-Biancamano MO; Bernard O; Riggs KW; Guillemette C; Ensom MH
    Pharmacotherapy; 2010 Nov; 30(11):1097-108. PubMed ID: 20973683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.
    Zhang WX; Chen B; Jin Z; Yu Z; Wang X; Chen H; Mao A; Cai W
    Xenobiotica; 2008 Nov; 38(11):1422-36. PubMed ID: 18946804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
    van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
    Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
    Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Metabolism Interaction Between p-Cresol and Mycophenolic Acid.
    Rong Y; Kiang TKL
    Toxicol Sci; 2020 Feb; 173(2):267-279. PubMed ID: 31742356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
    Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
    Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
    Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
    Naesens M; Kuypers DR; Streit F; Armstrong VW; Oellerich M; Verbeke K; Vanrenterghem Y
    Clin Pharmacol Ther; 2006 Nov; 80(5):509-21. PubMed ID: 17112807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.
    Iwamura A; Fukami T; Higuchi R; Nakajima M; Yokoi T
    J Biol Chem; 2012 Mar; 287(12):9240-9. PubMed ID: 22294686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.